IM Cannabis Corp.
IMCCNASDAQHealthcareDrug Manufacturers - Specialty & Generic
Previous close
$0.1128
−$0.0013 · -1.14%
IMCC company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Sell
Trim exposure — unfavorable risk-reward
Valuation
49
Fair Value
Momentum
17
Strong Down
Sentiment
52
Mixed
Risk resilience
19
Extreme Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteIM Cannabis Corp. specializes in the cultivation, production, and provision of medicinal cannabis goods throughout international markets such as Israel, Germany, and Canada. The company offers a range of cannabis products, including flowers and specifically formulated cannabis extracts, marketed under its IMC brand. Furthermore, it supplies dried flower, pre-rolled products, and compressed hashish via its WAGNERS and Highland Grow labels. IM Cannabis Corp. serves a broad customer base, addressing the needs of both medical patients and adult recreational consumers. Its corporate headquarters are located in Tel Aviv-Yafo, Israel.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Headquarters
- CA
- CEO
- Oren Shuster
- Listed since
- May 20, 2020
- Employees
- 44
Market position
Day range
Current $0.1128
52-week range
Current $0.1128
- Open
- $0.1165
- Previous close
- $0.1141
- Volume
- 937.82K
- 0.21× average
- Average volume
- 4.43M
- Average daily volume
- Market cap
- 348.04K USD
- Beta
- 2.06
- Market reference 1
- 50-day average
- $0.1468
- -23.17% below average
- 200-day average
- $0.722
- -84.38% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 21.63M CAD
- P/E (TTM)
- -1,062.5×
- P/B (TTM)
- 4.72×
- P/S (TTM)
- 0.68×
- EV / EBITDA
- -3.11×
- Earnings yield
- -139.99%
- Free cash flow yield
- 58.17%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 27.28%
- Operating margin
- -0.76%
- Net margin
- -0.53%
- Return on equity
- 1319.23%
- Return on assets
- -35.67%
- Return on invested capital
- -89.08%
Financial health
- Debt / equity
- 4.44×
- Current ratio
- 0.67×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (CAD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 54.73M CAD | 54.03M CAD | 48.8M CAD | 54.34M CAD | 34.05M CAD |
| Cost of goods sold | 45.05M CAD | 45.58M CAD | 38.96M CAD | 45.17M CAD | 27.72M CAD |
| Gross profit | 9.69M CAD | 8.45M CAD | 9.85M CAD | 9.16M CAD | 6.33M CAD |
| Selling, general, and administrative | 12.94M CAD | 13.28M CAD | 19.03M CAD | 28.91M CAD | 28.09M CAD |
| Operating expenses | 21.27M CAD | 18.69M CAD | 22.64M CAD | 39.95M CAD | 29.37M CAD |
| Interest income | — | 1.91M CAD | 7.01M CAD | 6.7M CAD | 23.54M CAD |
| Interest expense | 2.76M CAD | 4.47M CAD | 3.67M CAD | 1.97M CAD | 673K CAD |
| Depreciation and amortization | 1.96M CAD | 2.18M CAD | 3M CAD | 7.33M CAD | 5.73M CAD |
| Operating income | −11.59M CAD | −10.23M CAD | −12.79M CAD | −30.79M CAD | −23.04M CAD |
| Net income | −11.32M CAD | −10.59M CAD | −9.5M CAD | −188.89M CAD | −17.76M CAD |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 56%
- 5 beats, 4 misses, 0 met estimates
- Average EPS surprise
- -375.26%
- 9 comparable reports
- Latest EPS result
- -0.34
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
IMCC peers
Continue in GoAI
Research IMCCresearch.disclaimer